|
Today's Headlines
A coalition of doctors, addiction experts, and law enforcement officials are urging FDA to revoke approval of the powerful opioid Zohydro ER (hydrocodone bitartrate) extended-release capsules, which reportedly will contain 10 times more hydrocodone than Vicodin. » Full article
|
|
This season's flu vaccine has reduced the risk of influenza-associated medical visits by 61% across all age groups, according to the Centers for Disease Control and Prevention. Thus far it appears to be outperforming its predecessor from 2012 to 2013, which had an effectiveness rate of 51%. » Full article
|
Continuing Education
Drug Topics kicks off a new CPE series, MTM Considerations for Adult Patients with Cardiovascular Disease, which will include 12 knowledge-based activities worth up to 24 credits. The goal of the first activity, “MTM essentials for cholesterol management,” will empower pharmacists to utilize current understanding of cholesterol management to improve patient care. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.
Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide
or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at
www.MyCPEmonitor.net. This profile will enable you to have one login
for all the NABP programs and services you will need throughout your career.
|
|
EDITOR'S PICK
The brave new world of pharmaceutical economics and clinical outcomes continue to collide in the real world of healthcare delivery. A recent Bloomberg News story stated that Express Scripts plans a specialty drug price war over new hepatitis C treatments. That news follows the release of a new drug, sofosbuvir (Sovaldi, Gilead), which reportedly costs $1,000 per pill. » Full article
|
|
|
Like
Tweet
